Search Results - Andrea Sponghini

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study by Valentina D. A. Corino, Marco Bologna, Giuseppina Calareso, Lisa Licitra, Mariagrazia Ghi, Gaetana Rinaldi, Francesco Caponigro, Franco Morelli, Mario Airoldi, Giacomo Allegrini, Alessandra Cassano, Daris Ferrari, Aurora Mirabile, Alicia Tosoni, Danilo Galizia, Marco Merlano, Andrea Sponghini, Gabriella Moretti, Luca Mainardi, Paolo Bossi

    Published in Diagnostics (2021-05-01)
    Get full text
    Article


  2. 2

    An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer by Stefano Cavalieri, Mara Serena Serafini, Andrea Carenzo, Silvana Canevari, Deborah Lenoci, Federico Pistore, Rosalba Miceli, Stefania Vecchio, Daris Ferrari, Cecilia Moro, Andrea Sponghini, Alessia Caldara, Maria Cossu Rocca, Simona Secondino, Gabriella Moretti, Nerina Denaro, Francesco Caponigro, Emanuela Vaccher, Gaetana Rinaldi, Francesco Ferraù, Paolo Bossi, Lisa Licitra, Loris De Cecco

    Published in Cells (2022-10-01)
    Get full text
    Article


Search Tools: